RNS Number:6850D
Hikma Pharmaceuticals Plc
11 September 2007







                    Hikma Pharmaceuticals PLC - LTIP Awards



LONDON, 11 September 2007: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)
announces that the Remuneration Committee has made the following awards under
the Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the "LTIP") to
Directors/Persons Discharging Managerial Responsibility ("PDMRs") of the
Company.



Awards were made on 10 September 2007 at a price of #4.1225 per ordinary share
as follows:-



Name of PDMR                 Number of Shares awarded under the LTIP

Said Darwazah                100,000

Mazen Darwazah                50,000



The shares subject to the LTIP awards will only be released to the participants
in three years time, subject to their continued employment and the satisfaction
of the comparative Total Shareholder Return ("TSR") performance target.
Participants will only receive the full benefit of their share incentives if TSR
performance against the Comparator Group is at least at the upper quartile.



                                    - ENDS -

Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles                                                +44 20 7399 2760
Company Secretary

Susan Ringdal                                                +44 20 7399 2760
Investor Relations Director



About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products.  Hikma's operations
are conducted through three businesses: "Branded", "Injectables" and "Generics".
  Hikma's operations are based principally in the Middle East and North Africa
("MENA") region, where it is a market leader and sells across 17 countries, the
United States and Europe.  In 2006, the Group achieved revenues of $317 million
(2005 $262 million) and profit attributable to shareholders was $55 million
(2005 $44 million).  At 30 June 2007, the Group had over 2,700 employees.  For
news and other information, please visit www.hikma.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSMGGMLVMLGNZM
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.